National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

6. Anxiety disorders and substance use

prev pageTOC |next page

Table of contents

6.1 Anxiety

6.2 Comorbidity with anxiety disorders

6.3 Major clinical issues with anxiety disorders and cannabis/hallucinogen use

6.4 Major clinical issues with anxiety disorders and alcohol use

6.5 Major clinical issues with anxiety disorders and opioid use

6.6 Major clinical issues with anxiety disorders and stimulant (including methamphetamine) use

6.7 Major clinical issues with anxiety disorders and benzodiazepine use

6.8 Major clinical issues with anxiety disorders and inhalant/solvent use

prev pageTOC |next page